Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology
Sign Up to like & getrecommendations! Published in 2019 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2019.1698597
Abstract: Abstract The number of Parkinson’s disease (PD) patients with the advanced phase and motor fluctuations is increasing. The objective of this study is developing levodopa/benzylhydrazine orally disintegrating tablets (L/B ODTs), which would provide greater convenience… read more here.
Keywords: methodology; orally disintegrating; disintegrating tablets; levodopa benzylhydrazine ... See more keywords